Study S001987

Real-World Effectiveness, Safety, and Patient-Reported Outcomes of Tirzepatide in Adults With Type 2 Diabetes Mellitus, Obesity, or Prediabetes in Pakistan: A Multicentre, Prospective, Observational Cohort Study

ClinicalTrials.gov record

Registration

Registration: NCT07809568
Acronym: TRIBUTE-PK
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 330
Start: 2026-10-01
Primary completion: 2027-12-28
Lead sponsor: Universiti Sains Malaysia
Conditions: Prediabetes or Overweight; Obesity Type 2 Diabetes Mellitus; Obesity & Overweight
Results posted: FALSE
Individual participant data sharing: UNDECIDED
Secondary identifiers: OTHER_GRANT:R504-LR-GAL008-2600000333-B158

Registered primary outcomes

Percentage change in body weight (obesity and prediabetes cohorts) [Baseline to Week 26]
Change in HbA1c (type 2 diabetes cohort) [Baseline to Week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.